CaRi-heart technology
Revolutionary new technology to assess the risk of a serious heart condition or heart attack – many years before anything happens.
Read the latest news stories and press releases from HCA Healthcare UK in London, Birmingham and Manchester.
HCA Healthcare UK is increasing access to GP and preventative health services across London, responding to rising demand for convenient care that delivers faster diagnosis, clearer pathways and improved outcomes.
HCA Healthcare UK has announced that it has treated a metastatic lung cancer patient with tumour-infiltrating lymphocyte (TIL) therapy for the first time as part of a clinical trial at its research arm, Sarah Cannon Research Institute UK. The ground-breaking cellular therapy treatment represents a significant milestone in targeting advanced cancer, marking HCA UK's continued leadership in bringing cutting-edge immunotherapy treatments to patients in the UK.